• Altimmune partners with DynPort on intranasal Covid-19 vaccine pharmaceutical-technology
    July 13, 2020
    Biopharmaceutical firm Altimmune has signed a teaming agreement with DynPort Vaccine to support US Government funding efforts for the development of its intranasal Covid-19 vaccine candidate, AdCOVID.
  • Immune Regulation teams with DynPort on COVID-19 drug pharmatimes
    July 07, 2020
    US and UK-based clinical stage biotech Immune Regulation has signed a deal with DynPort Vaccine Company to jointly evaluate the potential of the former's ILR201104 to treat COVID-19 related Acute Respiratory Distress Syndrome (ARDS) in US clinical trials.
PharmaSources Customer Service